NCT00548613View on ClinicalTrials.gov

Combination Stem Cell (MESENDO) Therapy for Utilization and Rescue of Infarcted Myocardium

PHASE1CompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

October 31, 2007

Primary Completion Date

December 31, 2008

Study Completion Date

March 31, 2009

Conditions
Coronary Artery DiseaseCoronary ArteriosclerosisCoronary AtherosclerosisCoronary Disease
Interventions
BIOLOGICAL

MESENDO

Intracoronary transplantation of autologous stem cells via balloon catheter

BIOLOGICAL

MESENDO

Intracardiac transplantation of autologous stem cells via direct injection

Trial Locations (1)

70433

TCA Cellular Therapy, LLC, Covington

Sponsors
All Listed Sponsors
lead

TCA Cellular Therapy

INDUSTRY